Document is current
Any future updates will be listed below
-
Authors
Kuang, Fei Li
Bochner, Bruce S. https://orcid.org/0000-0002-9411-6009
-
Funding
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (U19 AI136443)
- License Information
-
More Information
Article History
Received: 10 January 2021
Accepted: 2 March 2021
First Online: 23 April 2021
Declarations
:
: Dr. Kuang has no conflict of interest to declare. Dr. Bochner receives publication-related royalty payments from Elsevier and UpToDate. He receives remuneration for consulting services (Glaxo SmithKline, Sanofi/Regeneron) and for serving on the scientific advisory board of Third Harmonic Bio, Inc. and Allakos, Inc. He also own stock in Allakos. Dr. Bochner is a co-inventor on existing Siglec-8–related patents and thus may be entitled to a share of royalties received by Johns Hopkins University during development and potential sales of such products. Dr. Bochner is a co-founder of Allakos, Inc. which makes him subject to certain restrictions under University policy. The terms of this arrangement are being managed by Johns Hopkins University and Northwestern University in accordance with their conflict of interest policies.
